DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.21% to $762.65 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.50% to 6,950.23 and the Dow Jones Industrial Average rising 0.64% to 49,412.40.
Regeneron Pharmaceuticals Inc. closed 7.12% short of its 52-week high of $821.11, which the company achieved on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 1.43% to $349.69, Moderna Inc. (MRNA) fell 1.48% to $47.99, and Gilead Sciences Inc. (GILD) rose 1.36% to $137.78.
Trading volume (932,882) remained 54,668 below its 50-day average volume of 987,550.
Data source: Dow Jones Market Data, FactSet. Data compiled January 26, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 26, 2026 16:42 ET (21:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.